OTC - ACTIVE INGREDIENT SECTION
Active Ingredient: TITANIUM DIOXIDE
Active Ingredient: TITANIUM DIOXIDE
Inactive Ingredients:
BUTYLENE GLYCOL DICAPRYLATE/DICAPRATE, DIMETHICONE, PHENYL TRIMETHICONE, HEXYLDECYL MYRISTOYL METHYLAMINOPROPIONATE, METHYL METHACRYLATE CROSSPOLYMER, NYLON-12, ETHYLHEXYL METHOXYCINNAMATE, SYNTHETIC WAX, TRIBEHENIN, TRIETHOXYCAPRYLYLSILANE, TOCOPHERYL ACETATE, SILICA, FRAGRANCE, METHICONE, METHYLPARABEN, HYDROLYZED COLLAGEN, ARTEMISIA ABROTANUM FLOWER/LEAF/STEM EXTRACT, EUCOMMIA ULMOIDES EXTRACT, CROCUS SATIVUS FLOWER EXTRACT,
(MAY CONTAIN) IRON OXIDES(CI 77491, 77492, 77499)
Warnings:
When using this product
Keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if
Rash or irritation develops and lasts.
Directions:
Apply evenly before sun exposure and as needed.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51523-008-01 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-c70b-621f-e053-dbdaa90a74ad | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51523-008-01 | FLEBEAUTE COLLAGENIC SKIN COVERSPF20 PA NB23 | 10 g in 1 CARTON | POWDER | 10 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 2 | |
| TITANIUM | ACTIVE MOIETY | D1JT611TNE | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51523-008 | 51523-008-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TITANIUM DIOXIDE | 15FIX9V2JP | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b104d6e5-9452-4844-806f-3f5dfa86dbde | bb66faeb-20c4-4ea8-a05b-4f9be8605475 | 2010-07-13 | b104d6e5-9452-4844-806f-3f5dfa86dbde bb66faeb-20c4-4ea8-a05b-4f9be8605475 |
Adverse event summaries are temporarily unavailable. Other product information remains available.